Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,413.83 -11.02 -0.07%
S&P 500 1,866.12 3.81 0.20%
NASDAQ 4,096.72 10.50 0.26%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,417.53 -0.15 -0.00%
TOPIX 1,166.59 0.04 0.00%
HANG SENG 22,760.24 64.23 0.28%

INVESTOR ALERT Levi & Korsinsky, LLP Announces Investigation of SOLTA MEDICAL, INC. and Its Board of Directors In Relation to



  INVESTOR ALERT Levi & Korsinsky, LLP Announces Investigation of SOLTA
  MEDICAL, INC. and Its Board of Directors In Relation to the Sale of the
  Company to Valeant Pharmaceuticals International, Inc.

Business Wire

NEW YORK -- December 17, 2013

Levi & Korsinsky is investigating the Board of Directors of Solta Medical,
Inc. (“Solta Medical”) (NasdaqGS: SLTM) for possible breaches of fiduciary
duty and other violations of state law in connection with the sale of the
Company to Valeant Pharmaceuticals International, Inc. (NYSE: VRX).

Click here to learn more about the action
http://zlk.9nl.com/solta-medical-sltm/, or call: 877-363-5972. There is no
cost or obligation to you.

Under the terms of transaction, Solta Medical shareholders will receive $2.92
in cash for each share of Solta Medical stock they own. The transaction has a
total approximate value of $250 million. The investigation concerns whether
the Solta Medical Board of Directors breached their fiduciary duties to
stockholders by failing to adequately shop the Company before agreeing to
enter into this transaction, and whether Valeant Pharmaceuticals
International, Inc. is underpaying for Solta Medical shares. In particular, at
least one analyst set a price target for Solta Medical stock at $4.00 per
share.

If you own Solta Medical common stock and wish to obtain additional
information, please contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or
visit http://zlk.9nl.com/solta-medical-sltm/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey,
Connecticut and Washington D.C. The firm’s 26 attorneys have extensive
expertise in prosecuting securities litigation involving financial fraud,
representing investors throughout the nation in securities and shareholder
lawsuits. For more information, please feel free to contact any of the
attorneys listed below. Attorney advertising. Prior results do not guarantee
similar outcomes.

Contact:

Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
Tel: 212-363-7500
Toll Free: 877-363-5972
Fax: 866-367-6510
www.zlk.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement